Ment et al. should be commended for undertaking the onerous task of
developing neuroimaging guidelines for the neonate. [1] This task is made
difficult by the heterogeneous definitions of neonatal brain injury,
different applications of the same technologies, and widely discrepant
study designs used since 1990 in neonatal neuroimaging studies. The
authors systematically reviewed this extensive literature and distilled a
number of practice parameters.
With respect to the premature newborn, this practice parameter must
be interpreted with caution, in view of the considerable advances in the
MR imaging of the premature newborn's brain that have been made in the
past 5 years. We and several other colleagues have been enrolling
premature newborns in prospective studies to determine the relationship
between MRI findings and neurodevelopmental outcome. As a result of these
studies the spectrum of white matter injury detectable by MRI is being
determined and the effects of early white matter injury on subsequent
brain development are being clarified. [2, 3, 4, 5, 6, 7, 8] It is
becoming increasingly clear that MRI detects lesions that are not detected
by ultrasound and that these lesions are associated with abnormal brain
development measured in a variety of ways. Furthermore, advanced MR
techniques, such as diffusion tensor imaging and MR spectroscopic imaging
offer the exciting possibility of detecting white matter injury at a time
when intervention is at least theoretically possible. [9, 10, 11]
However, to have meaningful neurodevelopmental follow-up data, cohorts
enrolled in study must reach at least 30 months of age. The wealth of
exciting preliminary data supporting the role of MRI in neuroimaging the
premature newborn presented at meetings in abstract form at the Society
for Pediatric Research and the International Society of Magnetic Resonance
in Medicine this year (2002) suggests that the literature will soon
contain the neurodevelopmental follow-up data that we are currently
lacking. [12, 13]
We recognize that the issue of “when” to establish guidelines is
difficult as the speed of scientific discovery continues to advance and
there is always new information on the horizon. Yet it is important to
recognize the potential bias of practice parameters in favoring techniques
that have been in use for a longer period of time, at the cost of novel
techniques that may be advantageous. During any given period of time,
older techniques are published more frequently as there is significant lag
-time until new techniques are adequately validated and accepted in the
literature. This is particularly true of MRI and neuroimaging the
premature newborn.
We congratulate the authors on their work with respect to
neuroimaging of the term newborn. However, the authors suggest that early
CT should be used to exclude hemorrhage, and MRI should be performed later
in the first postnatal week to establish pattern of injury due to
asphyxial damage. Neonatal encephalopathy is more often due to prenatal
causes such as inborn errors of metabolism, cerebral dysgenesis, or
intrauterine infection. [14] MRI helps to narrow the differential
diagnosis in the evaluation of an encephalopathic neonate who is not
dysmorphic but might have an underlying neurogenetic, neurovascular or
inflammatory disease requiring intervention. As the first step in caring
for an encephalopathic newborn is establishing the diagnosis, MRI early in
the first week of life is the diagnostic test of choice.
Equally important, in addition to helping establish a diagnosis in
the encephalopathic newborn, these MR techniques, in particular MR
spectroscopy performed at the same time as the MRI, can then provide
invaluable prognostic information for the care of these newborns. The
valuable prognostic capabilities of MRI and MRS were well illustrated by
the authors. Unfortunately, CT does not compare favorably with MRI for
confirming the diagnosis of hypoxic-ischemic brain injury or providing
prognostic information.
We sincerely hope that this practice parameter in defining clinical
guidelines will not be misused to limit clinical access and insurance
coverage for optimal imaging modalities for newborns.
Finally, we would like to commend Ment et al. for highlighting the
need of future research related to imaging the newborn brain.
References:
1. Ment LR, Bada, MD, Barnes P, et al. Practice parameter:
Neuroimaging of the neonate. Report of the Quality Standards Subcommittee
of the American Academy of Neurology and the Practice Committee of the
Child Neurology Society. Neurology 2002;58:1726-1738.
2. Hüppi PS, Warfield S, Kikinis R. et al. Quantitative magnetic
resonance imaging of brain development in premature and mature newborns.
Annals of Neurology 1998;43:224-235.
3. Maalouf EF, Duggan PJ, Rutherford MA, et al. Magnetic resonance
imaging of the brain in a cohort of extremely preterm infants. Journal of
Pediatrics 1999;135:351-357.
4. Maalouf EF, Dugan PJ, Counsell SJ, et al. Comparison of findings
on cranial ultrasound and magnetic resonance imaging in preterm infants.
Pediatrics 2001;107:719-727.
5. van Wezel-Meijler G, van der Knaap MS, Sie LT, et al. Magnetic
resonance imaging of the brain in premature infants during the neonatal
period. Normal phenomena and reflection of mild ultrasound abnormalities.
Neuropediatrics 1998;29:89-96.
6. Inder TE, Hüppi PS, Warfield S, et al. Periventricular white
matter injury in the premature infant is followed by reduced cerebral
cortical gray matter volume at term. Annals of Neurology 1999;46:755-760.
7. Groenendaal F, van der Grond J, Eken P, et al. Early cerebral
proton MRS and neurodevelopmental outcome in infants with cystic
leukomalacia. Developmental Medicine and Child Neurology 1997;39:373-379.
8. Sie LT, van der Knapp MS, van Wezel-Meijler G. Taets van Amerongen
AH, Lafeber HN, Valk J. Early MR features of hypoxic-ischemic brain
injury in neonates with periventricular densities on sonograms. AJNR Am J
Neuroradiol 2000;21:852-861.
9. Vigneron DB, Barkovich AJ, Noworolski SM, et al. Three-dimensional
proton MR spectroscopic imaging of premature and term neonates. AJNR Am J
Neuroradiol 2001;22:1424-1433.
10.Hüppi PS, Maier SE, Peled S, et al. Micostructural development of
human newborn cerebral white matter assessed in vivo by diffusion tensor
magnetic resonance imaging. Pediatric Research 1998;44:584-590.
11.Inder T, Hüppi PS, Zientara GP, et al. Early detection of
periventricular leukomalacia by diffusion-weighted magnetic resonance
imaging techniques [see comments]. Journal of Pediatrics 1999;134:631-634.
12.Pediatric Academic Societies’ Annual Meeting. Program Issue.
Pediatric Research 2002;51:438A-440A.
13.Proceedings of the ISMRM, 10th Annual Meeting (Honolulu), 2002.
14.Nelson KB, Grether JK. Selection of neonates for neuroprotective
therapies: One set of criteria applied to a population. Arch Pediatr
Adolesc Med 1999;153:393-398.